URINARY BLADDER NEOPLASM
Clinical trials for URINARY BLADDER NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASM trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called LY4052031, which is designed to deliver a cancer-killing agent directly to tumor cells that have a protein called Nectin-4. The study includes 420 adults with advanced or metastatic solid tumors such as bladder, breast, lung, and oth…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a breast cancer drug combo treat rare tumors?
Disease control Recruiting nowThis trial tests two drugs, trastuzumab and pertuzumab, already approved for breast cancer, in people with rare cancers that have a specific genetic change called HER2 amplification or mutation. About 30 adults and children with various rare or hard-to-treat cancers will receive …
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New immunotherapy combo may save bladders in cancer patients
Disease control Recruiting nowThis phase 2 trial tests two immunotherapy drugs, nivolumab and relatlimab, given before surgery for stage II-IIIa bladder cancer. The goal is to see if the combination can eliminate the tumor, allowing patients to keep their bladder instead of having it removed. About 90 partici…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 26, 2026 12:50 UTC